India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
How is Ayurvedic treatment for asthma done? Asthma is a chronic inflammatory disease of the respiratory system. It is characterized by various symptoms including wheezing, excessive coughing, and difficulty breathing. According to current statistics, more than one million people in Nepal are affected by various types of respiratory problems, most of which are children and the elderly. According to a study conducted in the Kathmandu Valley, about 7.5 percent of school-age children experience occasional wheezing, 5.2 percent have persistent difficulty breathing, 16 percent have nighttime coughing, and 9.4 percent experience asthma symptoms during exercise. Similarly, other chronic diseases are becoming more complicated due to asthma in the elderly. In such a situation, in recent times, there has been an increasing interest in Ayurvedic treatment for the treatment of asthma in Nepal. Asthma patients are getting relief from Ayurvedic medicines, Panchakarma, yoga, and herbal treatments...